Global genomics focus LC Sciences operates as a global biotechnology provider serving genomics and proteomics researchers, presenting opportunities to cross-sell microarray services, targeted sequencing workflows, and custom oligonucleotide solutions to international research teams and CROs.

Cost and speed advantages OligoMix and VariantPro offer cost reductions and faster sequencing workflows, suggesting sales potential in labs aiming to scale multiplexed experiments, improve coverage efficiency, and reduce per-sample sequencing depth.

Custom platform offerings Core technologies such as µParaflo microfluidic on-chip synthesis, OligoFix error correction, and multiplex PCR-based targeted sequencing create upsell opportunities for developers seeking bespoke microarrays, aptamer screening, and synthetic biology applications.

Biomarker and drug discovery fit LC Sciences’ services span biomarker discovery and drug development workflows, aligning with pharma and biotech customers pursuing targeted sequencing, proteomics assays, and epitope mapping to accelerate research programs.

Strategic partnerships Past collaboration with Nano3D Biosciences and AstraZeneca indicates receptiveness to research partnerships; pursue co-development or joint marketing with biotechs and contract research organizations to expand adoption of LC Sciences technologies.